V. Padalka¹, N. Kurdil², M. Zinovіeva², G. Petrashenko²

¹ SI "Ukrainian Scientific and Practical Center for Emergency Medical Care and Medicine Disaster of the Ministry of Health of Ukraine", Kyiv, Ukraine
² L.I. Medved’s Research Center of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Interprise), Kyiv, Ukraine

ABSTRACT. Vitamin D-related health problems remain a global health problem. The growing number of prescriptions of vitamin D by doctors during the COVID-19 pandemic and the increase in self-intake of vitamin D by the population carries the risk of exogenous hypervitaminosis D, or a syndrome known as vitamin D toxicity.

Aim: to summarize the results of scientific research on the vitamin D toxicity, and some aspects related to its overdose.

Material and Methods: used methods of content analysis, system and comparative analysis; materials of scientific reviews and separate researches devoted to biochemistry and toxicology of vitamin D (Elsevier, PubMed, ToxNet) with depth of search to 20 years.

Results and Discussion. Due to the well-known health risks of vitamin D deficiency, it has become a popular dietary supplement, as evidenced by the progressive growth of both thematic scientific publications (PubMed) and its consumption in many countries around the world. The use of pharmaceuticals and dietary supplements is the most common cause of overdose. A review of cases of vitamin D toxicity caused by errors in prescribing or administering the required dose has shown that they may occasionally be accompanied by the development of intoxication. There are many forms of exogenous and endogenous vitamin D toxicity syndrome. Vitamin D toxicity syndrome includes the following symptoms: loss of consciousness, apathy, intermittent vomiting, abdominal pain, polyuria, polydipsia, dehydration, and hypercalcemia, which, although uncommon, can be life-threatening if not detected timely, and is an important symptom in the differential diagnosis in patients with hypercalcemia. Despite differing opinions on the target concentration of 25(OH)D or recommended doses of vitamin D for the general population, it was determined that the concentration of 25 (OH) D> 150 ng/ml is a significant risk of developing vitamin D toxicity syndrome, and vitamin D deficiency treatment regimens at high doses require regular monitoring.

Conclusions: There is a growing public awareness of the health benefits of vitamin D; however, the increase in its consumption carries, inter alia, the risk of a specific syndrome ‒ the vitamin D toxicity. Family physicians should be informed about the danger of exceeding the recommended (age and body weight) doses, and carry out explanatory work with the public to raise awareness of adverse effects vitamin D overdose.

Key Words: vitamin D, toxicity.

СПИСОК ВИКОРИСТАНОЇ ЛІТЕРАТУРИ (ДЖЕРЕЛ) / REFERENCES

1. Chang SW, Lee HC. Vitamin D and health – The missing vitamin in humans. Pediatr Neonatol. 2019 Jun;60(3):237-244.

2. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016 Jan;96(1):365-408.

3. Bouillon R. Vitamin D and Extraskeletal Health. UpToDate (2015). Available online at: www.uptodate.com

4. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. (2014) 21:319–29. doi: 10.1016/j.chembiol.2013.12.016

5. Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, et al. Monthly high-dose vitamin d treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. (2016) 176:175–83. doi: 10.1001/jamainternmed.2015.7148

6. Deluca HF, Prahl JM, Plum LA. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or25-hydroxyvitamin D. Arch Biochem Biophys. (2011) 505:226–30. doi: 10.1016/j.abb.2010.10.012

7. Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients. 2013 Sep 13;5(9):3605-16. doi: 10.3390/nu5093605.

8. Asif A, Farooq N. Vitamin D Toxicity. 2021 Apr 29. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2021 Jan–. PMID: 32491799 Free Books & Documents. Review.

9. Charoenngam N, Hossein-Nezhad A, Hanley DA, Holick MF. Misconception about the cause of vitamin D toxicity. CMAJ. 2019 Jul 8;191(27):E769. doi: 10.1503/cmaj.72511.

10. Galior K, Grebe S. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Singh R. Nutrients. 2018 Jul 24;10(8):953. doi: 10.3390/nu10080953.

11. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. (2008) 88:582–6. doi: 10.1093/ajcn/88.2.582S.

12. Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. (1995) 43:531–6.

13. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D–binding protein. J Clin Endocrinol Metab. (1986) 63:954–9.

14. Bikle DD, Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology (1989) 124:649–54.

15. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med. (1995) 122:511–3.).

16. Holick MF. Vitamin D is not as toxic as was once thought: a historical and up-to-date perspective. Mayo Clin Proc. (2015) 90:561–4. doi: 10.1016/j.mayocp.2015.03.015

17. Corbet-Dooren J. Supplements may not prevent bone fractures.Wall Street Journal. 2013. Electronic resource. Access mode. URL: https://www.wsj.com/articles/SB10001424127887323884304578326580034502690.

18. Martineau AR, Forouhi NG. Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol. 2020 Sep;8(9):735‒736.

19. Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putativeroles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021 Jan 15;292:198‒235.

20. Trovas G, Tournis S. Vitamin D and COVID-19. Hormones (Athens). 2021 Mar;20(1):207-208.

21. Marcinowska-Suchowierska E, Kupisz-UrbańskaM, ŁukaszkiewiczJ, PłudowskiP, Jones G. Vitamin D Toxicity-A Clinical Perspective. Front Endocrinol (Lausanne). 2018 Sep 20;9:550. doi: 10.3389/fendo.2018.00550.

22. Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, et al. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol. (2016) 27:604–14. doi: 10.1681/ASN.2014101025

23. Pronicka E, Ciara E, Halat P, Janiec A, Wуjcik M, Rowinska E, et al. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases. J Appl Genet. (2017) 58:349–53. doi: 10.1007/s13353-017-0397-2.

24. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. (2011) 3655:410–21. doi: 10.1056/NEJMoa1103864

25. Potts JT Jr, Juppner H. Disorders of the parathyroid gland and calcium homeostasis. In: Longo DL, Fauci AS, Kasper Dl, Hauser Sl, Jameson Jl, Loscalzo J, editors. Harrison's Principles of Internal Medicine. Vol. 2. 18th ed. New York, NY: McGraw Hill. (2012). p. 3096–3129.

26. Dinour D, Davidovits M, Aviner S. Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake. Pediatr Nephrol. (2015) 30:145–52. doi: 10.1007/s00467-014-2889-1

27. Farnaghi F, Hassanian-Moghaddam H, Zamani N, Gholami N, Gachkar L, Hosseini Yazdi M. Vitamin D toxicity in a pediatric toxicological referral center; a cross-sectional study from Iran. BMC Pediatr. 2020 Jul 20;20(1):350. doi: 10.1186/s12887-020-02240-4.

28. Häusler D, Torke S, Peelen E, Bertsch T, Djukic M, Nau R, Larochelle C, Zamvil SS, Brьck W, Weber MS. High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium. Brain. 2019 Sep 1;142(9):2737-2755. doi: 10.1093/brain/awz190.

29. Chatterjee R, Chatterjee K, Sen C. Reversible Parkinsonism Due to Vitamin D Toxicity. J Neurosci Rural Pract. 2017 Apr-Jun;8(2):305-306. doi: 10.4103/jnrp.jnrp_497_16.

30. Gupta AK, Jamwal V, Sakul, Malhotra P. Hypervitaminosis D and systemic manifestations: a comprehensive review. JIMSA (2014) 27:236–7.

31. Sarma A. Vitamin D toxicity presenting with altered sensorium and hypercalcaemia. Indian J Anaesth. 2020 Oct;64(10):909-911. doi: 10.4103/ija.IJA_166_20.

32. Demer LL, Hsu JJ, Tintut Y. Steroid Hormone Vitamin D: Implications for Cardiovascular Disease. Circ Res. 2018 May 25;122(11):1576-1585.

33. Jones G, Schlingmann KP. Hypercalcemic states associated with abnormalities of vitamin D metabolism. Front Horm Res. (2018) 50:89–113. doi: 10.1159/000486073

34. Cusano N, Thys-Jacobs S, Bilezikian JP. Hypercalcemia due to vitamin D toxicity. In: Feldman D, Pike JW, Adams JS, editor. Vitamin D. London, UK: Elsevier (2011). p. 1394.

35. Lim K, Thadhani R. Vitamin D Toxicity. J Bras Nefrol. 2020 Apr 3;42(2):238-244. doi: 10.1590/2175-8239-JBN-2019-0192.

36. Taylor PN, Davies JS.A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018 Jun;84(6):1121-1127. doi: 10.1111/bcp.13573.

37. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007 Dec;22 Suppl 2:V64-8. doi: 10.1359/jbmr.07s221.

38. Virmani A. Vitamin D toxicity. Indian Pediatr. 2014 Jan;51(1):63.

39. Khieng V, Stevens C. Vitamin D toxicity: a case study. N Zeal J Med Lab Sci. (2010) 64:44–50.

40. Maji D. Vitamin D toxicity. Indian J Endocrinol Metab. 2012 Mar;16(2):295-6. doi: 10.4103/2230-8210.93773.

41. Misgar RA, Sahu D, Bhat MH, Wani AI, Bashir MI. Vitamin D Toxicity: A Prospective Study from a Tertiary Care Centre in Kashmir Valley. Indian J Endocrinol Metab. 2019 May-Jun;23(3):363-366. doi: 10.4103/ijem.IJEM_116_19.

42. Tebben PJ, Singh RJ, Kumar R. Vitamin D–mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev. (2016) 37:521–47. doi: 10.1210/er.2016-1070

43. Bell NH, Stern PH, Pantzer E, Sinha TK, DeLuca HF. Evidence that increased circulating 1α, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. (1979) 64:218–25. doi: 10.1172/JCI109442

44. Mudde AH, vandenBerg H, Boshuis PG, Breedveld FC, Markusse HM, Kluin PM, etal. Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer (1987) 59:1543–6.

45. Ziaie H, Razmjou S, Jomhouri R, Jenabi A. Vitamin D Toxicity; Stored and Released from Adipose Tissue? Arch Iran Med. 2016 Aug;19(8):597-600.

46. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. (2008) 88:582–6. doi: 10.1093/ajcn/88.2.582S

47. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE (2014)9:e111265. doi: 10.1371/journal.pone.0111265

48. Rizzoli R. Vitamin D supplementation: upper limit for safety revisited? Aging clinical and experimental research. 2020 Aug 28:1‒6.

49. Durazo-Arvizu RA, Dawson-Hughes B, Kramer H, Cao G, Merkel J, Coates PM, et al. The reverse j-shaped association between serum total 25-Hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization. Am J Epidemiol. (2017) 185:720–6. doi: 10.1093/aje/kww244

50. Dudenkov DV, Yawn BP, Oberhelman SS, Fischer PR, Singh RJ, Cha SS, et al. Changing incidence of serum 25-hydroxyvitamin D values above 50 ng/ml: a 10-year population-based study. Mayo Clin Proc. (2015) 90:577–86. doi: 10.1016/j.mayocp.2015.02.012

51. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. (2011) 96:1911–30. doi: 10.1210/jc.2011-0385

52. Ross AC, Manson JE, Abrams SA etal (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58.

Стаття надійшла до редакції 10.06.2021 / Received June 10, 2021